cardiovascular disaster in hemodialysis patients
DESCRIPTION
Cardiovascular Disaster in Hemodialysis patients. Pattaraporn MD. Causes of death in prevalent dialysis patients 2008-2010. 41.6%. 26.5%. Cardiovascular Disaster. Sudden death . Unexpected natural death Within a short time period >> 1-24 h Due to cardiac etiology - PowerPoint PPT PresentationTRANSCRIPT
Cardiovascular Disaster in Hemodialysis patients
Pattaraporn MD.
Causes of death in prevalent dialysis patients 2008-2010
41.6%
26.5%
Cardiovascular Disaster
Sudden death
• Unexpected natural death• Within a short time period >> 1-24 h• Due to cardiac etiology• New or more serious symptoms
Possible Mechanisms Responsible for SD in HD
Cardiac arrest
QT dispersion
Cardiac arrhythmia
cardiomyopathy
Ischecmic heart disease
•Myocardial interstitial fibrosis•Microvessel disease•CHF•CAD/MI•LVH/LV dysfunction
Rapid electrolyte shifts/Hypervolemia
Inflammation
Sympathetic overactivity
Left ventricular Hypertrophy and Heart failure
Concentric LV hypertrophy Eccentric LV hypertrophy
Left ventricular Hypertrophy and Heart failure
• LVH is an powerful indicator of mortality in dialysis patients
• Presence of LVH >>> arrhythmia• Left ventricular systolic dysfunction >>
arrhythmia
Redaelli B: Lancet 1988;ii:305–309.
Myocardial Interstitial fibrosis and Microvessel disease
Inadequate capillary density + increased oxygen demand >> relative hypoxia >> fibrosis
Myocardial Interstitial fibrosis and Microvessel disease
• Fibrous tissue >> high electrical resistance• Development of atrial and ventricular reentry
types of arrhythmias• Risk factor for the development of
arrhythmias especially during the dialysis
QT Dispersion
• Difference between the longest and shortest QT intervals >> EKG 12 lead
• Predict an increased risk of malignant arrhythmias• Normal value of QT dispersion in normal subjects
was ≤40 ms• Dialysis patients with QT dispersion > 74 ms >>
ventricular arrhythmias or SD• Low K+ and low Ca2+ >> acquired long QT syndrome
Sympathetic overactivity
• Heart rate >> myocardial demand supply >> cardiac hypertrophy and fibrosis
• Decrease heart rate variability (reflecting autonomic dysfunction) >> increased risk for all-cause and SD in HD
• Marker : C-reactive protein, inhibit the hepatic generation of albumin
• Reflection of vascular injury VS actually promotes vascular injury ?
• High CRP level ( >6 mg/l ) : independent , predictive marker of future myocardial infarction– Herzig, K. A. et al. J. Am. Soc. Nephrol. 12, 814–821 (2001).
• Inflammation could trigger SD >> atherosclerosis or direct effect on myocardium
Inflammation
Other factors
• Rapid electrolyte shifts• Hypervolemia • Anemia • Dyslipidemia • Hypertension • Calcium/phosphate deposition
Prevention of Sudden Death
Beta-blocker
Implantable defibrillators
Avoiding low Kdialysate & rapidelectrolyte shifts
ACEI andARBs
Beta-blocker
• Reduction of– Cardiac hypertrophy & fibrosis– Antifibrillary activity– Ventricular arrhythmia– Reduced risk of acute MI
• Improve Heart rate variability• Increase in baroreflex sensitivity
ACEI andARBs
• Reduction of– Cardiac hypertrophy & fibrosis– Fatal arrhythmia
Avoiding low K dialysate & rapidelectrolyte shifts:
• To avoid– QT dispersion– Re entrant arrhythmias‐– Premature ventricular extrasystole (VES)
Implantable defibrillators or Implantable Cardioverter Defibrillators (ICDs)
• Most effective therapy for SCD in the general population• Indication – Survival of cardiac arrest due to VT or VF– Episode of sustained VT causing severe hemodynamic
compromise– Episode of sustained VT without hemodynamic compromise
+ EF 35%– MI + EF 35% + nonsustained VT on 24-h ECG + inducible VT
on electrophysiologic testing– MI + EF 30% QRS duration 120 ms on ECG
• 42% risk reduction for death in dialysis patients with ICDs implanted according to conventional guidelines
• Greater risk of device complications• No statistically increase >>> infection or
fistula thrombosis
– Kidney Int. 2005;68:818-825.
Implantable defibrillators or Implantable Cardioverter Defibrillators (ICDs)
Herzog CA et al. Kidney Int. 2005;68:818-825.
Thank You